Dexrazoxane Preserved Cardiac Function in Children Undergoing Chemotherapy for AML

A study found that dexrazoxane, a cardioprotective drug, preserved cardiac function without compromising overall survival and event-free survival for pediatric patients with acute myeloid leukemia.

Source: CancerNetwork - May 18, 2020 Category: Cancer & Oncology Authors: Matthew Fowler Source Type: news